Quanterix (QTRX) IPO Opens 8% Higher

Today's IPO for Quanterix Corporation (NASDAQ: QTRX) opened for trading at $16.25 after pricing 4,275,200 shares of its common stock at a public offering price of $15.00 per share.

In addition, Quanterix has granted the underwriters a 30-day option to purchase up to 641,280 additional shares of common stock at the initial public offering price, less the underwriting discount.

J.P. Morgan Securities LLC, Leerink Partners LLC and Cowen and Company, LLC are serving as joint book-running managers for the offering. BTIG, LLC and Evercore Group L.L.C. are serving as co-managers.

Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.

You May Also Be Interested In

• Rubrik IPO: 5 key things to know
• Junee Ltd (JUNE) Prices 2M Share IPO at $4/sh
• Brilliance Group (KHIW) Files for 2.5M Share IPO at $4-$4.50/sh